DEAN SMITH: Open Payments
NPI 1811963390 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 39 payments from 17 companies in 2025. Trend: 2023 $623 · 2024 $826 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Caris MPI, Inc. | 1 | $80 |
| Novo Nordisk Inc | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| PFIZER INC. | 3 | $53 |
| Dexcom, Inc. | 2 | $49 |
| ABBVIE INC. | 3 | $49 |
| Amgen Inc. | 3 | $48 |
Products named: XIFAXAN, MI CANCER SEEK, INTERSTIM, LEQVIO, Dexcom G6 Transmitter, OTEZLA, VOQUEZNA, SHINGRIX.
Industry payments across SC — which companies pay providers there.
